Search for content and authors |
New 1-(2-pirydynyl)-6-substituted imidazo[1,2-a][1,3,5]- triazine with potential pharmacological activity. |
Elżbieta Szacoń 1, Marzena Rządkowska 1, Dariusz Matosiuk 1, Ewa Kędzierska 2, Sylwia Fidecka 2 |
1. Medical University, Faculty of Pharmacy, Department of Synthesis and Chemical Technology of Pharmaceutical Substances, Staszica 6, Lublin 20-081, Poland |
Abstract |
The aminocarbonyl derivatives of 1- aryl-2-imidazolidine-2 have significant antinociceptive activity connected with activation of the MOP (mu opioid protein) receptor [1-3].The syntnetic derivatives of triazepine form are various and important group of medicine.In the search for new derivatives with potential pharmacological activity received of new imidazo [1,2-a][1,3,5]triazine. New 1-(2-pirydynyl)-6-fenyl(benzyl)-5,6,8(1H)-dioxoimidazo[1,2-a][1,3,5]triazine and 1-[2-(5-nitro)pirydynyl]-6-fenyl(benzyl)-5,6,8(1H)- dioxoimidazo[1,2-a][1,3,5]triazine were synthesised in reaction of adequate substituted 1-[(2-pirydynyl)imidazolidine-2-ylideno]- 3-fenyl(benzyl)urea with CDI. The structure of all new compounds was confirmed by elementar analysis, as well by the 1H NMR.
[1] D. Matosiuk, S. Fidecka, L. Antkiewicz-Michaluk, I. Dybała, A.E.Kozioł, Eur. J. Med.. Chem. 2001, 36 783 [2] D. Matosiuk, S. Fidecka, L. Antkiewicz-Michaluk, J. Lipkowski, I. Dybała, A.E.Kozioł, Eur. J. Med.. Chem. 2002, 37 761 [3] K.Sztanke, S. Fidecka, E. Kędzierska, Z. Karczmarzyk, K. Pihlaja, D. Matosiuk, Eur. J. Med.. Chem. 2005, 40 127
|
Legal notice |
|
Related papers |
Presentation: Poster at VII Multidyscyplinarna Konferencja Nauki o Leku, by Elżbieta SzacońSee On-line Journal of VII Multidyscyplinarna Konferencja Nauki o Leku Submitted: 2010-03-12 10:34 Revised: 2010-04-05 21:20 |